PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Medicine. vicmutua3@gmail.com.\', \'. brandon.henry@cchmc.org.\', \'. csefalvayk@starschema.net.\', \'. isaacbmn@outlook.com.\', \'. jensvikse@gmail.com.\', \'. giuseppe.lippi@unvir.it.\', \'. nyamweya9083@gmail.com.\', \'. newnexmongare@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.23750/abm.v93i1.12208
?:doi
?:hasPublicationType
?:journal
  • Acta bio-medica : Atenei Parmensis
is ?:pmid of
?:pmid
?:pmid
  • 35315395
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all